title: Allosteric modulation of glycine receptors is more efficacious for partial rather than full agonists.
abstract: Allosteric modulation of [3H]strychnine binding to glycine receptors (GlyRs) was examined in synaptosomal membranes of rat spinal cord. An allosteric model enabled us to determine the cooperativity factors of the allosteric agents with [3H]strychnine and glycine bindings (alpha and beta, respectively). We modified the allosteric model with a slope factor because the slope values of the displacement curves of partial agonists (beta-alanine, taurine and gamma-aminobutyric acid) were beyond unity. The slope factor was reduced only by 100 microM propofol. Further, propofol showed positive cooperativity (beta < 1) stronger with taurine than with glycine. The extent of the positive cooperativity of propofol was nearly independent from the potencies and structures of partial agonists. The steroidal alphaxalone and minaxolone also potentiated taurine better than glycine. Alphaxalone exerted weak negative cooperativity with [3H]strychnine binding. Displacement by taurine is attenuated by granisetron and m-chlorophenylbiguanide representing negative cooperativity (beta >> 1) greater than with glycine. The results suggest a developmental role of elevated perinatal levels of taurine and neurosteroids as well as a better allosteric modulation of decreased agonist efficacies for impaired glycine receptor-ionophores.
authors.affiliation: Department of Molecular Pharmacology, Chemical Research Center, Hungarian Academy of Sciences, H-1525 Budapest, POB 17, Hungary.
authors.forename: Tímea
authors.initials: T
authors.lastname: Bíró
authors.forename: Gábor
authors.initials: G
authors.lastname: Maksay
mesh_terms: D000409:Alanine / Q000737:chemistry / Q000494:pharmacology; D000465:Algorithms; D018686:Anesthetics, Intravenous; D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D004357:Drug Synergism; D018684:Glycine Agents / Q000737:chemistry / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D015742:Propofol / Q000494:pharmacology; D051381:Rats; D018009:Receptors, Glycine / Q000819:agonists*; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism; D013237:Stereoisomerism; D013331:Strychnine / Q000494:pharmacology; D013654:Taurine / Q000737:chemistry / Q000494:pharmacology; D015032:Zinc / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000737:chemistry / Q000494:pharmacology
chemical_list: D018686:Anesthetics, Intravenous; D018684:Glycine Agents; D018009:Receptors, Glycine; D013654:Taurine; D005680:gamma-Aminobutyric Acid; D013331:Strychnine; D015032:Zinc; D000409:Alanine; D015742:Propofol